(VIANEWS) - The Market ended the session with CARASENT (CARA.OL) jumping 28.18% to kr14.10 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 1.01% to kr1,353.28, after four successive sessions in a row of losses, on what was an all-around positive trend trading session today.
CARASENT's last close was kr11.00, 53.49% under its 52-week high of kr23.65.
About CARASENT
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, CARASENT has a trailing twelve months EPS of kr-0.6.
Return on Equity
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -4.05%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CARASENT's stock is considered to be oversold (<=20).
More news about CARASENT (CARA.OL).